Renaissance Technologies
DERM icon

Renaissance Technologies’s Journey Medical DERM Stock Holding History

Renaissance Technologies’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
229,700
-12,800
-5% -$73.1K ﹤0.01% 2083
2026
Q1 		$1.14M Sell
242,500
-1,500
-0.6% -$11.6K ﹤0.01% 2201
2025
Q4 		$1.88M Sell
244,000
-3,900
-2% -$30.6K ﹤0.01% 1902
2025
Q3 		$1.77M Buy
247,900
+4,400
+2% +$31.9K ﹤0.01% 2156
2025
Q2 		$1.75M Buy
243,500
+5,500
+2% +$38K ﹤0.01% 2198
2025
Q1 		$1.4M Buy
238,000
+2,000
+0.8% +$9.83K ﹤0.01% 2203
2024
Q4 		$923K Sell
236,000
-32,200
-12% -$176K ﹤0.01% 2539
2024
Q3 		$1.52M Buy
268,200
+4,175
+2% +$21.5K ﹤0.01% 2194
2024
Q2 		$1.49M Sell
264,025
-6,575
-2% -$27.1K ﹤0.01% 2072
2024
Q1 		$996K Buy
270,600
+9,600
+4% +$41.8K ﹤0.01% 2486
2023
Q4 		$1.5M Buy
261,000
+240,100
+1,149% +$1.07M ﹤0.01% 2132
2023
Q3 		$57K Buy
20,900
+9,400
+82% +$21K ﹤0.01% 3378
2023
Q2 		$18K Buy
+11,500
New +$18.5K ﹤0.01% 3784
2022
Q2 		– Sell
-15,600
Closed -$75K – 4285
2022
Q1 		$75K Buy
+15,600
New +$77.9K ﹤0.01% 3843

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies's DERM Position: Q2 2026 in Review

Renaissance Technologies reduced its Journey Medical (DERM) stake by 5.3% in Q2 2026, selling an estimated $73.1K and leaving 229,700 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Renaissance Technologies first reported a position in DERM in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.88M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Renaissance Technologies held 229,700 shares of Journey Medical worth $1.63M as of Q2 2026.
  • Renaissance Technologies sold 12,800 Journey Medical shares in Q2 2026, an estimated $73.1K.
  • Journey Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2083 holding.
  • Renaissance Technologies first reported a position in Journey Medical in Q1 2022 and has held it in 14 quarters since.
  • Renaissance Technologies's Journey Medical position peaked at $1.88M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.